Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
- Bill Number
- H.Res. 93
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Congress
- Status
- Passed House
- Latest Action
- 2025-02-05: Motion to reconsider laid on the table Agreed to without objection.
- Last Updated
- 2026-07-11T20:09:46Z
AI-Generated Summary
Purpose
H. Res. 93 is a procedural resolution in the U.S. House of Representatives that sets the rules for debating and voting on H.R. 27, a bill aimed at amending the Controlled Substances Act (CSA) to address the scheduling of fentanyl-related substances and other related matters.
Key Provisions
- Waiver of Objections: All points of order (procedural challenges) against considering H.R. 27 are waived, allowing the bill to move forward without typical hurdles.
- Adoption of Amendment: An amendment from part A of the Committee on Rules report is automatically adopted, and the bill is treated as already read.
- Debate and Amendments:
- Limits debate to one hour, split equally between the chair and ranking minority member of the Committee on Energy and Commerce (or their designees).
- Allows one specific further amendment from part B of the Rules Committee report, offered by a designated member, which is debatable for a set time (divided equally between supporter and opponent) and not subject to division or other procedural delays.
- Orders the "previous question" on the bill and any further amendments, blocking additional changes and leading directly to a vote.
- Recommit Motion: Permits one motion to send the bill back to committee for further review.
- Final Passage: The process ends with a vote on final passage without intervening motions, except as specified.
Significant Changes to Existing Law
This resolution does not directly amend existing law; it is a House rule that streamlines the consideration of H.R. 27. If H.R. 27 passes, it would change the CSA by updating how fentanyl-related substances are classified and controlled (e.g., potentially adding them to stricter schedules under the CSA, which regulates drugs based on abuse potential and medical use). The resolution itself modifies standard House procedures by waiving objections and limiting debate, expediting the bill's path compared to regular order.
Potential Impacts
- On Government Agencies: Could accelerate changes to drug enforcement policies, affecting agencies like the Drug Enforcement Administration (DEA) in scheduling and regulating fentanyl analogs, potentially enhancing tools to combat the opioid crisis.
- On Citizens: May lead to stricter controls on fentanyl-related drugs, impacting public health efforts against overdoses while possibly affecting access to certain substances for medical or research purposes.
- On International Relations: Indirectly influences U.S. drug policy, which could affect cooperation with international partners on narcotics control, such as through treaties or border enforcement.
Main Stakeholders
- Legislators: Members of the House, particularly those on the Committee on Energy and Commerce and the Committee on Rules, who control debate and amendments.
- Law Enforcement and Health Agencies: DEA, Department of Health and Human Services (HHS), and state-level drug control bodies, which implement CSA changes.
- Public Health Advocates and Affected Communities: Individuals and groups dealing with opioid addiction, pharmaceutical companies, and researchers working on fentanyl-related substances.
- General Public: U.S. citizens impacted by drug policy, especially in regions hit hard by fentanyl overdoses.
Notable Legal, Constitutional, or Political Implications
- Legal: Reinforces the House's authority under Article I of the U.S. Constitution to set its own rules for debate and passage of bills, ensuring H.R. 27 can advance without procedural blocks.
- Constitutional: Aligns with Congress's power to regulate interstate commerce and public health via the CSA, but the bill's amendments (if enacted) could raise questions about balancing drug control with individual rights under the Fourth and Fifth Amendments (e.g., in enforcement contexts).
- Political: As a partisan or expedited process (common for priority issues like the opioid crisis), it may highlight divisions between majority and minority parties on drug policy timing and scope, potentially influencing broader legislative agendas in the 119th Congress.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Griffith, H. Morgan [R-VA-9]
Recent Actions
- 2025-02-05: Motion to reconsider laid on the table Agreed to without objection.
- 2025-02-05: On agreeing to the resolution Agreed to by recorded vote: 215 - 208 (Roll no. 31). (text: CR H469) (Roll call 31)
- 2025-02-05: Passed/agreed to in House: On agreeing to the resolution Agreed to by recorded vote: 215 - 208 (Roll no. 31). (text: CR H469) (Roll call 31)
- 2025-02-05: On ordering the previous question Agreed to by the Yeas and Nays: 212 - 208 (Roll no. 30). (consideration: CR H482) (Roll call 30)
- 2025-02-05: Considered as unfinished business. (consideration: CR H482-483)
- 2025-02-05: POSTPONED PROCEEDINGS - At the conclusion of debate on H. Res. 93, the Chair put the question on ordering the previous question and by voice vote announced that the ayes had prevailed. Mr. McGovern demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
- 2025-02-05: DEBATE - The House proceeded with one hour of debate on H. Res. 93.
- 2025-02-05: Considered as privileged matter. (consideration: CR H469-478)
- 2025-02-04: Placed on the House Calendar, Calendar No. 2.
- 2025-02-04: The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.
- 2025-02-04: The House Committee on Rules reported an original measure, H. Rept. 119-2, by Mr. Griffith.
- 2025-02-04: The House Committee on Rules reported an original measure, H. Rept. 119-2, by Mr. Griffith.
Bill Versions
- Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes. — issued 2025-02-05 — PDF (2 pages)
- Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes. — issued 2025-02-04 — PDF (4 pages)